1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.84%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-3.95%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-24.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-64.68%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-34.02%
Negative net income growth while 1113.HK stands at 140.12%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-34.71%
Negative EPS growth while 1113.HK is at 142.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-31.31%
Negative diluted EPS growth while 1113.HK is at 142.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.27%
Slight or no buybacks while 1113.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.55%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
67.69%
Positive OCF growth while 1113.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
45912.08%
Positive FCF growth while 1113.HK is negative. John Neff would see a strong competitive edge in net cash generation.
98192.55%
10Y revenue/share CAGR above 1.5x 1113.HK's 136.91%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
489.72%
Positive 5Y CAGR while 1113.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
115.01%
Positive 3Y CAGR while 1113.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
248.29%
OCF/share CAGR of 248.29% while 1113.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
342.41%
Positive OCF/share growth while 1113.HK is negative. John Neff might see a comparative advantage in operational cash viability.
596.77%
Positive 3Y OCF/share CAGR while 1113.HK is negative. John Neff might see a big short-term edge in operational efficiency.
1844.27%
Net income/share CAGR above 1.5x 1113.HK's 9.71% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
168.03%
Positive 5Y CAGR while 1113.HK is negative. John Neff might view this as a strong mid-term relative advantage.
155.77%
3Y net income/share CAGR similar to 1113.HK's 142.50%. Walter Schloss would attribute it to shared growth factors or demand patterns.
-4.80%
Negative equity/share CAGR over 10 years while 1113.HK stands at 1889.42%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
3.97%
Below 50% of 1113.HK's 28.32%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
35.34%
3Y equity/share CAGR above 1.5x 1113.HK's 12.92%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-94.27%
Cut dividends over 10 years while 1113.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.27%
Inventory shrinking or stable vs. 1113.HK's 11.36%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-61.88%
Negative asset growth while 1113.HK invests at 3.44%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-100.00%
We have a declining book value while 1113.HK shows 1.76%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
15.45%
Debt growth far above 1113.HK's 5.15%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
4.08%
SG&A declining or stable vs. 1113.HK's 363.02%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.